Literature DB >> 23933911

Butyrylcholinesterase and γ-glutamyltransferase activities and oxidative stress markers are altered in metabolic syndrome, but are not affected by body mass index.

Karine S De Bona1, Gabriela Bonfanti, Paula E R Bitencourt, Lariane O Cargnelutti, Priscila S da Silva, Leidiane De Lucca, Victor C Pimentel, Etiane Tatsch, Thissiane L Gonçalves, Melissa Premaor, Rafael N Moresco, Maria Beatriz Moretto.   

Abstract

Metabolic syndrome (MetS) leads to changes in enzymatic activities, oxidative and inflammatory parameters. Adenosine deaminase (ADA), dipeptidyl peptidase IV (DPP-IV), butyrylcholinesterase (BuChE) and γ-glutamyltransferase (γ-GT) activities, C-reactive protein (hsCRP) and nitric oxide levels (NOx), as well as oxidative stress markers were analyzed in 39 subjects with MetS and 48 controls. Also, the influence of body mass index (BMI) and anthropometric measurements were evaluated. Disturbances in antioxidant defenses and higher γ-GT and BuChE activities, NOx and hsCRP levels were observed in subjects with MetS. These findings remained associated with MetS after adjustment for BMI, except for hsCRP. ADA was correlated with age, insulin levels and HOMA-IR index in MetS. DPP-IV and total cholesterol (TC), BuChE activity and TC, and VIT C and hsCRP levels also were correlated. The analyzed parameters may reflect the inflammatory state of the MetS, and could contribute to prevention and control of various aspects of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23933911     DOI: 10.1007/s10753-013-9697-9

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  46 in total

1.  Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

Authors:  Jakob Ryskjaer; Carolyn F Deacon; Richard D Carr; Thure Krarup; Sten Madsbad; Jens Holst; Tina Vilsbøll
Journal:  Eur J Endocrinol       Date:  2006-09       Impact factor: 6.664

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

3.  A methodology for analysis of tissue sulfhydryl components.

Authors:  A F Boyne; G L Ellman
Journal:  Anal Biochem       Date:  1972-04       Impact factor: 3.365

4.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

5.  Dipeptidyl peptidase IV in patients with systemic lupus erythematosus.

Authors:  M Stancíková; Z Lojda; J Lukác; M Ruzicková
Journal:  Clin Exp Rheumatol       Date:  1992 Jul-Aug       Impact factor: 4.473

6.  Serum nitric oxide metabolites in subjects with metabolic syndrome.

Authors:  Saleh Zahedi Asl; Asghar Ghasemi; Fereidoun Azizi
Journal:  Clin Biochem       Date:  2008-09-03       Impact factor: 3.281

7.  Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus.

Authors:  C A Abbott; M I Mackness; S Kumar; A O Olukoga; C Gordon; S Arrol; D Bhatnagar; A J Boulton; P N Durrington
Journal:  Clin Sci (Lond)       Date:  1993-07       Impact factor: 6.124

8.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

Authors:  Tobias Pischon; Frank B Hu; Kathryn M Rexrode; Cynthia J Girman; Joann E Manson; Eric B Rimm
Journal:  Atherosclerosis       Date:  2007-08-02       Impact factor: 5.162

9.  The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford
Journal:  Atherosclerosis       Date:  2003-06       Impact factor: 5.162

10.  Adenosine deaminase activity in the serum of type 2 diabetic patients.

Authors:  Naciye Kurtul; Sadrettin Pence; Ersin Akarsu; Hasan Kocoglu; Yemliha Aksoy; Hülya Aksoy
Journal:  Acta Medica (Hradec Kralove)       Date:  2004
View more
  4 in total

1.  Maternal circulating levels of some metabolic syndrome biomarkers in gestational diabetes mellitus.

Authors:  Ali Khosrowbeygi; Najmeh Shiamizadeh; Nima Taghizadeh
Journal:  Endocrine       Date:  2015-07-29       Impact factor: 3.633

2.  Contribution of Inflammation, Oxidative Stress, and Antioxidants to the Relationship between Sleep Duration and Cardiometabolic Health.

Authors:  Thirumagal Kanagasabai; Chris I Ardern
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

3.  Reduced vagal control of the heart in high-fat diet mice: a potential role of increased butyrylcholinesterase.

Authors:  Sigurd Hartnett; Hongbo Gao; Sabrina Schnack; Yifan Li
Journal:  Physiol Rep       Date:  2015-11

4.  Metabolic Syndrome Augments the Risk of Early Neurological Deterioration in Acute Ischemic Stroke Patients Independent of Inflammatory Mediators: A Hospital-Based Prospective Study.

Authors:  Xiaohao Zhang; Zhiguang Sun; Caixia Ding; Yinyan Tang; Xuemei Jiang; Yi Xie; Chuanyou Li; Lankun Zhang; Dan Hu; Tingting Li; Gelin Xu; Lei Sheng
Journal:  Oxid Med Cell Longev       Date:  2016-03-29       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.